Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

Pre-existing HIV drug resistance can jeopardize first-line antiretroviral therapy (ART) success. Changes in the prevalence of drug resistance-associated mutations (DRMs) were analyzed from HIV-infected, ART-naive, U.S. individuals seeking ART treatment from 2000 to 2009. HIV DRM data from 3,829 ART-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Lisa L., Shortino, Denise, Shaefer, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080107/
https://www.ncbi.nlm.nih.gov/pubmed/29732898
http://dx.doi.org/10.1089/aid.2017.0295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080107/
https://www.ncbi.nlm.nih.gov/pubmed/29732898
http://dx.doi.org/10.1089/aid.2017.0295

Ejemplares similares